CD14分子(CD14)活性蛋白
Active Cluster Of Differentiation 14 (CD14)
Monocyte differentiation antigen CD14; Myeloid cell-specific leucine-rich glycoprotein
- 編號(hào)APA685Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)8.5
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 2016 ¥ 5040 ¥ 10080 ¥ 30240 ¥ 75600
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
Figure. The binding activity of CD14 with LBP.
Cluster Of Differentiation 14 (CD14), also known as CD14, is a component of the innate immune system. CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns such as lipoteichoic acid. Besides, Lipopolysaccharide Binding Protein (LBP) has been identified as an interactor of CD14, thus a binding ELISA assay was conducted to detect the interaction of recombinant human CD14 and recombinant human LBP. Briefly, CD14 were diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to LBP-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CD14 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of CD14 and LBP was shown in Figure 1, and this effect was in a dose dependent manner.
CD14 also can enhance LPS-stimulated IL-8 secretion by THP-1 human acute monocytic leukemia cells. Therefore, THP1 cells were cultured in 24 well plates at a concentration of 106 cells/mL and stimulated by LPS (1μg/mL), then added of different concentrations of recombinant human CD14 (1μg/mL, 5μg/mL). After 24h later, the production of IL8 was determined in the supernatants by cytokine specific ELISA.
Result: When the concentration of CD14 was 5μg/mL, the secretion LPS-stimulated IL-8 can be significantly increased.
The standard curve was demonstrated as follows.
Figure. Effects of CD14 on IL8 production by THP1?cells.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
EPA685Hu62 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA685Hu62 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. |
APA685Hu01 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA685Hu02 | CD14分子(CD14)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA685Hu01 | CD14分子(CD14)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA685Hu61 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. |
EPA685Hu61 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA685Hu64 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA685Hu01 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. |
PAA685Hu06 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. |
PAA685Hu02 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. |
FAA685Hu01 | 抗CD14分子(CD14)多克隆抗體 | Flow cytometry. |
FAA685Hu03 | 抗CD14分子(CD14)多克隆抗體 | Flow cytometry. |
LAA685Hu71 | CD14分子(CD14)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA685Hu27 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu29 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu23 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu22 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu21 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu24 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu25 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
MAA685Hu26 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
RAA685Hu25 | CD14分子(CD14)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
FAA685Hu02 | 抗CD14分子(CD14)單克隆抗體 | FCM |
FAA685Hu86 | 抗CD14分子(CD14)單克隆抗體(異硫氰酸熒光素標(biāo)記) | FCM |
SEA685Hu | CD14分子(CD14)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA685Hu | CD14分子(CD14)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA685Hu01 | CD14分子(CD14)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages [Aspet: 171462] |
Tumour Biol | Elevated serum soluble CD15 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma [PubMed: 26643894] |
Free Patents online | RHEUMATOID ARTHRITIS RELATED BIOMARKER [20170350884] |
Intensive Care Research | Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD [] |